Ligand Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LGND and other ETFs, options, and stocks.

About LGND

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company that involves clinical development and commercialization of high-value medicines. Its platforms, Captisol and NITRICI, offer technology with broad applicability in drug development to a large network of biopharmaceutical partners, including the largest pharmaceutical manufacturers in the world. 

CEO
Todd Christopher Davis
CEOTodd Christopher Davis
Employees
47
Employees47
Headquarters
Jupiter, Florida
HeadquartersJupiter, Florida
Founded
1987
Founded1987
Employees
47
Employees47

LGND Key Statistics

Market cap
5.90B
Market cap5.90B
Price-Earnings ratio
40.19
Price-Earnings ratio40.19
Dividend yield
Dividend yield
Average volume
355.47K
Average volume355.47K
High today
$305.65
High today$305.65
Low today
$293.70
Low today$293.70
Open price
$303.51
Open price$303.51
Volume
395.25K
Volume395.25K
52 Week high
$326.63
52 Week high$326.63
52 Week low
$129.55
52 Week low$129.55

Stock Snapshot

The current Ligand Pharmaceuticals(LGND) stock price is $293.99, with a market capitalization of 5.9B. The stock trades at a price-to-earnings (P/E) ratio of 40.19.

On 2026-07-21, Ligand Pharmaceuticals(LGND) stock traded between a low of $293.70 and a high of $305.65. Shares are currently priced at $293.99, which is +0.1% above the low and -3.8% below the high.

Ligand Pharmaceuticals(LGND) shares are trading with a volume of 395.25K, against a daily average of 355.47K.

In the last year, Ligand Pharmaceuticals(LGND) shares hit a 52-week high of $326.63 and a 52-week low of $129.55.

In the last year, Ligand Pharmaceuticals(LGND) shares hit a 52-week high of $326.63 and a 52-week low of $129.55.

LGND News

TipRanks 3d
Ligand Pharmaceuticals Inc Q3 2024 Earnings Report - Results, Call & Slides - TipRanks

...

Ligand Pharmaceuticals Inc Q3 2024 Earnings Report - Results, Call & Slides - TipRanks
Simply Wall St 5d
Ligand Pharmaceuticals Closes XOMA Deal, Is The Stock Still Below Fair Value?

Ligand Pharmaceuticals (LGND) has completed its approximately US$739 million cash acquisition of XOMA Royalty Corporation, adding seven commercial products and...

Ligand Pharmaceuticals Closes XOMA Deal, Is The Stock Still Below Fair Value?
TipRanks 6d
Ligand Pharma completes transformative XOMA royalty acquisition

TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE. R...

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own LGND. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.